Description

▪ Introduction
Tren Med 200 by Pharma Nevis is a long-acting injectable anabolic formulation containing 200 mg/mL of Trenbolone Enanthate. It is formulated to support anabolic recovery in clinical and veterinary environments, particularly in the management of catabolic conditions, severe undernutrition, surgical rehabilitation, or tissue-wasting syndromes.

Trenbolone Enanthate promotes enhanced nitrogen retention, protein synthesis, and muscle preservation, while minimizing breakdown during metabolic distress. Its long-acting enanthate ester ensures a sustained hormonal release, making it suitable for less frequent administration while maintaining stable plasma concentrations.

Pharma Nevis produces Tren Med 200 under strict GMP-compliant standards, guaranteeing sterility, compound purity, and batch-to-batch consistency for professional use in regulated medical protocols.

▪ Product Details

• Active Ingredient: Trenbolone Enanthate

• Concentration: 200 mg/mL

• Form: Injectable solution (intramuscular)

• Brand: Pharma Nevis

• Packaging: 10 mL multi-dose vial

• Use: Licensed clinical or research use only

▪ Pharmacokinetics

• Half-life: Approximately 7–10 days

• Onset: Gradual, sustained anabolic activity

• Dosing Interval: Typically once or twice weekly under medical supervision

▪ Administration Guidelines

• Typical Dosage: As directed by a licensed medical professional

• Route: Intramuscular injection

• Frequency: Weekly or biweekly, depending on clinical protocol

▪ Disclaimer
This product is intended for licensed medical professionals and is not suitable for individuals under 18, pregnant or breastfeeding women, or for non-therapeutic or recreational use. Use must comply with regional laws, medical guidelines, and institutional policies.